Long-Term Efficacy, Complete Scalp Hair Regrowth, and Normal Body Hair and Nails in Patients with Alopecia Areata Receiving Ritlecitinib 50 mg Once Daily Up to 3 Years in the ALLEGRO Clinical Trial Program
July 2026
in “
Journal of the American Academy of Dermatology
”
Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer